down arrow

Beijing Scitop Bio-Tech Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004181
  • SHE: 300858
CNY
15.12
-0.56 (-3.57%)

Sep 23

SHE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Beijing Scitop Bio-Tech Co., Ltd.

Why is Beijing Scitop Bio-Tech Co., Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 0.70% and Operating profit at -9.35% over the last 5 years
2
Negative results in Mar 26
  • ROCE(HY) Lowest at 4.86%
  • INTEREST COVERAGE RATIO(Q) Lowest at 15,310.83
  • OPERATING PROFIT(Q) Lowest at CNY 8.66 MM
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -7.75% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Scitop Bio-Tech Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Beijing Scitop Bio-Tech Co., Ltd.
-13.55%
0.07
52.87%
China Shanghai Composite
3.0%
1.20
14.07%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.70%
EBIT Growth (5y)
-9.35%
EBIT to Interest (avg)
78.74
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
0.18
Tax Ratio
6.82%
Dividend Payout Ratio
27.88%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.43%
ROE (avg)
7.69%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
2.02
EV to EBIT
45.96
EV to EBITDA
32.91
EV to Capital Employed
2.74
EV to Sales
8.00
PEG Ratio
NA
Dividend Yield
1.05%
ROCE (Latest)
5.95%
ROE (Latest)
4.70%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
RAW MATERIAL COST(Y)

Fallen by 0.88% (YoY

-23What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 105.72 MM

ROCE(HY)

Lowest at 4.38%

DEBT-EQUITY RATIO (HY)

Highest at -38.35 %

NET SALES(Q)

Lowest at CNY 84.51 MM

OPERATING PROFIT(Q)

Lowest at CNY 14.95 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 17.69 %

PRE-TAX PROFIT(Q)

Lowest at CNY 8.08 MM

NET PROFIT(Q)

Lowest at CNY 8.66 MM

EPS(Q)

Lowest at CNY 0.04

Here's what is working for Beijing Scitop Bio-Tech Co., Ltd.

Raw Material Cost
Fallen by 0.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Beijing Scitop Bio-Tech Co., Ltd.

Pre-Tax Profit
At CNY 8.08 MM has Fallen at -66.16%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 8.66 MM has Fallen at -57.4%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow
Lowest at CNY 105.72 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales
Lowest at CNY 84.51 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit
Lowest at CNY 14.95 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 17.69 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at CNY 8.08 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit
Lowest at CNY 8.66 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS
Lowest at CNY 0.04
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debt-Equity Ratio
Highest at -38.35 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Non Operating Income
Highest at CNY 0.39 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income

Footer loading